Cargando…
New Drug Candidate Targeting the 4A1 Orphan Nuclear Receptor for Medullary Thyroid Cancer Therapy
Medullary thyroid cancer (MTC) is a relatively rare thyroid cancer responsible for a substantial fraction of thyroid cancer mortality. More effective therapeutic drugs with low toxicity for MTC are urgently needed. Orphan nuclear receptor 4A1 (NR4A1) plays a pivotal role in regulating the proliferat...
Autores principales: | Zhang, Lei, Liu, Wen, Wang, Qun, Li, Qinpei, Wang, Huijuan, Wang, Jun, Teng, Tieshan, Chen, Mingliang, Ji, Ailing, Li, Yanzhang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017334/ https://www.ncbi.nlm.nih.gov/pubmed/29498706 http://dx.doi.org/10.3390/molecules23030565 |
Ejemplares similares
-
The Orphan Nuclear Receptor 4A1: A Potential New Therapeutic Target for Metabolic Diseases
por: Zhang, Lei, et al.
Publicado: (2018) -
Epigallocatechin-3-gallate inhibits the growth and increases the apoptosis of human thyroid carcinoma cells through suppression of EGFR/RAS/RAF/MEK/ERK signaling pathway
por: Wu, Dongdong, et al.
Publicado: (2019) -
Design of new drugs for medullary thyroid carcinoma
por: Li, Yanqing, et al.
Publicado: (2022) -
Exogenous Hydrogen Sulfide Regulates the Growth of Human Thyroid Carcinoma Cells
por: Wu, Dongdong, et al.
Publicado: (2019) -
Identification and Characterization of pantocin wh-1, a Novel Cyclic Polypeptide Produced by Pantoea dispersa W18
por: Teng, Tieshan, et al.
Publicado: (2020)